Arm morbidity after breast-conserving therapy for breast cancer.
Identifieur interne : 004512 ( PubMed/Checkpoint ); précédent : 004511; suivant : 004513Arm morbidity after breast-conserving therapy for breast cancer.
Auteurs : I. Tengrup [Suède] ; L. Tennvall-Nittby ; I. Christiansson ; M. LaurinSource :
- Acta oncologica (Stockholm, Sweden) [ 0284-186X ] ; 2000.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Aisselle, Amplitude articulaire, Bras, Complications postopératoires, Douleur (étiologie), Femelle, Humains, Lymphoedème (étiologie), Mastectomie partielle (effets indésirables), Morbidité, Métastase lymphatique, Radiothérapie adjuvante (effets indésirables), Sujet âgé, Tumeurs du sein (), Tumeurs du sein (anatomopathologie), Tumeurs du sein (radiothérapie), Études de suivi.
- MESH :
- anatomopathologie : Tumeurs du sein.
- effets indésirables : Mastectomie partielle, Radiothérapie adjuvante.
- radiothérapie : Tumeurs du sein.
- étiologie : Douleur, Lymphoedème.
- Adulte, Adulte d'âge moyen, Aisselle, Amplitude articulaire, Bras, Complications postopératoires, Femelle, Humains, Morbidité, Métastase lymphatique, Sujet âgé, Tumeurs du sein, Études de suivi.
English descriptors
- KwdEn :
- Adult, Aged, Arm, Axilla, Breast Neoplasms (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Lymphedema (etiology), Mastectomy, Segmental (adverse effects), Middle Aged, Morbidity, Pain (etiology), Postoperative Complications, Radiotherapy, Adjuvant (adverse effects), Range of Motion, Articular.
- MESH :
- adverse effects : Mastectomy, Segmental, Radiotherapy, Adjuvant.
- etiology : Lymphedema, Pain.
- pathology : Breast Neoplasms.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Adult, Aged, Arm, Axilla, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Middle Aged, Morbidity, Postoperative Complications, Range of Motion, Articular.
Abstract
This study reports on 110 consecutive patients, mean age 59 years, operated on for partial mastectomy and axillary dissection. Radiotherapy of 50 Gy was administered to 75 of the patients. Most tumours were T1 tumours and all patients were NO. Lymphoedema is defined as an increase in arm volume > 10% and impaired shoulder mobility as an impairment of 15 degrees compared with the preoperative value. After operation, 21 patients developed lymphoedema, 17 in the radiotherapy group and 4 in the group without radiotherapy; 49% of the patients had reduced shoulder mobility, and of these, 57% were in the radiotherapy group and 30% in the group without radiotherapy. We found a good correlation between the number of patients stating arm swelling and patients with registered lymphoedema. There were fewer patients stating limitation of movement than patients with registered impaired mobility; 31% of patients were still perceiving some pain five years after the operation. We conclude, that breast-conserving therapy in breast cancer is afflicted with a significant arm morbidity that persists for several years after surgery.
PubMed: 10987237
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:10987237Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Arm morbidity after breast-conserving therapy for breast cancer.</title><author><name sortKey="Tengrup, I" sort="Tengrup, I" uniqKey="Tengrup I" first="I" last="Tengrup">I. Tengrup</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, University Hospital of Malmö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Surgery, University Hospital of Malmö</wicri:regionArea><wicri:noRegion>University Hospital of Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Tennvall Nittby, L" sort="Tennvall Nittby, L" uniqKey="Tennvall Nittby L" first="L" last="Tennvall-Nittby">L. Tennvall-Nittby</name></author><author><name sortKey="Christiansson, I" sort="Christiansson, I" uniqKey="Christiansson I" first="I" last="Christiansson">I. Christiansson</name></author><author><name sortKey="Laurin, M" sort="Laurin, M" uniqKey="Laurin M" first="M" last="Laurin">M. Laurin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10987237</idno><idno type="pmid">10987237</idno><idno type="wicri:Area/PubMed/Corpus">004997</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004997</idno><idno type="wicri:Area/PubMed/Curation">004997</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004997</idno><idno type="wicri:Area/PubMed/Checkpoint">004997</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004997</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Arm morbidity after breast-conserving therapy for breast cancer.</title><author><name sortKey="Tengrup, I" sort="Tengrup, I" uniqKey="Tengrup I" first="I" last="Tengrup">I. Tengrup</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, University Hospital of Malmö, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Surgery, University Hospital of Malmö</wicri:regionArea><wicri:noRegion>University Hospital of Malmö</wicri:noRegion></affiliation></author><author><name sortKey="Tennvall Nittby, L" sort="Tennvall Nittby, L" uniqKey="Tennvall Nittby L" first="L" last="Tennvall-Nittby">L. Tennvall-Nittby</name></author><author><name sortKey="Christiansson, I" sort="Christiansson, I" uniqKey="Christiansson I" first="I" last="Christiansson">I. Christiansson</name></author><author><name sortKey="Laurin, M" sort="Laurin, M" uniqKey="Laurin M" first="M" last="Laurin">M. Laurin</name></author></analytic><series><title level="j">Acta oncologica (Stockholm, Sweden)</title><idno type="ISSN">0284-186X</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Arm</term><term>Axilla</term><term>Breast Neoplasms (pathology)</term><term>Breast Neoplasms (radiotherapy)</term><term>Breast Neoplasms (surgery)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Lymphedema (etiology)</term><term>Mastectomy, Segmental (adverse effects)</term><term>Middle Aged</term><term>Morbidity</term><term>Pain (etiology)</term><term>Postoperative Complications</term><term>Radiotherapy, Adjuvant (adverse effects)</term><term>Range of Motion, Articular</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Amplitude articulaire</term><term>Bras</term><term>Complications postopératoires</term><term>Douleur (étiologie)</term><term>Femelle</term><term>Humains</term><term>Lymphoedème (étiologie)</term><term>Mastectomie partielle (effets indésirables)</term><term>Morbidité</term><term>Métastase lymphatique</term><term>Radiothérapie adjuvante (effets indésirables)</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (anatomopathologie)</term><term>Tumeurs du sein (radiothérapie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Mastectomy, Segmental</term><term>Radiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Mastectomie partielle</term><term>Radiothérapie adjuvante</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term><term>Pain</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Douleur</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Arm</term><term>Axilla</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymphatic Metastasis</term><term>Middle Aged</term><term>Morbidity</term><term>Postoperative Complications</term><term>Range of Motion, Articular</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aisselle</term><term>Amplitude articulaire</term><term>Bras</term><term>Complications postopératoires</term><term>Femelle</term><term>Humains</term><term>Morbidité</term><term>Métastase lymphatique</term><term>Sujet âgé</term><term>Tumeurs du sein</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study reports on 110 consecutive patients, mean age 59 years, operated on for partial mastectomy and axillary dissection. Radiotherapy of 50 Gy was administered to 75 of the patients. Most tumours were T1 tumours and all patients were NO. Lymphoedema is defined as an increase in arm volume > 10% and impaired shoulder mobility as an impairment of 15 degrees compared with the preoperative value. After operation, 21 patients developed lymphoedema, 17 in the radiotherapy group and 4 in the group without radiotherapy; 49% of the patients had reduced shoulder mobility, and of these, 57% were in the radiotherapy group and 30% in the group without radiotherapy. We found a good correlation between the number of patients stating arm swelling and patients with registered lymphoedema. There were fewer patients stating limitation of movement than patients with registered impaired mobility; 31% of patients were still perceiving some pain five years after the operation. We conclude, that breast-conserving therapy in breast cancer is afflicted with a significant arm morbidity that persists for several years after surgery.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10987237</PMID><DateCreated><Year>2000</Year><Month>09</Month><Day>28</Day></DateCreated><DateCompleted><Year>2000</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2009</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0284-186X</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><Issue>3</Issue><PubDate><Year>2000</Year></PubDate></JournalIssue><Title>Acta oncologica (Stockholm, Sweden)</Title><ISOAbbreviation>Acta Oncol</ISOAbbreviation></Journal><ArticleTitle>Arm morbidity after breast-conserving therapy for breast cancer.</ArticleTitle><Pagination><MedlinePgn>393-7</MedlinePgn></Pagination><Abstract><AbstractText>This study reports on 110 consecutive patients, mean age 59 years, operated on for partial mastectomy and axillary dissection. Radiotherapy of 50 Gy was administered to 75 of the patients. Most tumours were T1 tumours and all patients were NO. Lymphoedema is defined as an increase in arm volume > 10% and impaired shoulder mobility as an impairment of 15 degrees compared with the preoperative value. After operation, 21 patients developed lymphoedema, 17 in the radiotherapy group and 4 in the group without radiotherapy; 49% of the patients had reduced shoulder mobility, and of these, 57% were in the radiotherapy group and 30% in the group without radiotherapy. We found a good correlation between the number of patients stating arm swelling and patients with registered lymphoedema. There were fewer patients stating limitation of movement than patients with registered impaired mobility; 31% of patients were still perceiving some pain five years after the operation. We conclude, that breast-conserving therapy in breast cancer is afflicted with a significant arm morbidity that persists for several years after surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tengrup</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Surgery, University Hospital of Malmö, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tennvall-Nittby</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Christiansson</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Laurin</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Oncol</MedlineTA><NlmUniqueID>8709065</NlmUniqueID><ISSNLinking>0284-186X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015412" MajorTopicYN="N">Mastectomy, Segmental</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>9</Month><Day>15</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2000</Year><Month>9</Month><Day>30</Day><Hour>11</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>9</Month><Day>15</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10987237</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suède</li></country></list><tree><noCountry><name sortKey="Christiansson, I" sort="Christiansson, I" uniqKey="Christiansson I" first="I" last="Christiansson">I. Christiansson</name><name sortKey="Laurin, M" sort="Laurin, M" uniqKey="Laurin M" first="M" last="Laurin">M. Laurin</name><name sortKey="Tennvall Nittby, L" sort="Tennvall Nittby, L" uniqKey="Tennvall Nittby L" first="L" last="Tennvall-Nittby">L. Tennvall-Nittby</name></noCountry><country name="Suède"><noRegion><name sortKey="Tengrup, I" sort="Tengrup, I" uniqKey="Tengrup I" first="I" last="Tengrup">I. Tengrup</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004512 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004512 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:10987237
|texte= Arm morbidity after breast-conserving therapy for breast cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:10987237" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |